September 19, 2014 6:27 AM ET

Pharmaceuticals

Company Overview of Wockhardt USA, Inc.

Company Overview

Wockhardt USA, Inc. manufactures oral solids, liquids, topicals, and injectables. It offers prostate drugs; and tablets for the treatment of depression. The company was founded in 2004 and is based in Parsippany, New Jersey with manufacturing facilities in the United States, Europe, and India. Wockhardt USA, Inc. operates as a subsidiary of Wockhardt Ltd.

20 Waterview Boulevard

3rd Floor

Parsippany, NJ 07054

United States

Founded in 2004

Phone:

973-257-4960

Fax:

973-257-4961

Key Executives for Wockhardt USA, Inc.

President
Age: 47
Assistant Vice President of Finance & Information Technology
Vice President of Operations & Restructuring
Senior Director of Tech Services & NPD
Vice President and General Counsel
Compensation as of Fiscal Year 2014.

Wockhardt USA, Inc. Key Developments

Avanir Pharmaceuticals Receives Markman Claim Construction Ruling

Avanir Pharmaceuticals received a Markman claim construction ruling by Judge Leonard P. Stark of the United States District Court for the District of Delaware in Avanir’s ongoing patent infringement case against Actavis South Atlantic LLC, Actavis Inc., Par Pharmaceutical, Inc., Par Pharmaceutical Companies, Inc., Impax Laboratories, Inc., Wockhardt Ltd., Wockhardt USA, LLC, Watson Pharmaceuticals, Inc., Watson Laboratories, Inc., and Watson Pharma, Inc. In a Markman ruling, the court determines the meaning of disputed patent terms at issue in patent litigation. Judge Stark’s ruling construed five terms in the patents asserted by Avanir in the litigation. After comprehensive briefing and oral argument, Judge Stark issued an order adopting Avanir’s proposed or stipulated patent term constructions. Avanir filed suit against the Defendants in response to Abbreviated New Drug Applications filed by the Defendants seeking to market and sell generic versions of the currently approved dose of NUEDEXTA® prior to the expiration of U.S. patents 7,659,282, 8,227,484 and RE 38,115. Avanir filed the lawsuits on the basis that the defendants’ proposed generic products infringe certain patents held by Avanir. Although the parties intend to vigorously defend and enforce their patent rights, Avanir cannot predict timing or outcome of this action. Any adverse outcome in the litigation described above could adversely impact Avanir and its revenues.

Similar Private Companies By Industry

Company Name Region
Cobrek Pharmaceuticals, Inc. United States
Eaton Scientific Systems Ltd. United States
Cannabinoid Science Systems, Inc. United States
Peak Biopharma Corp. United States
Celeres Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Wockhardt USA, Inc., please visit www.wockhardtusa.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.